SUBSCRIBE
SUBSCRIBE
News   Drug Development

Takeda Pharmaceutical Co. Ltd. Starts Japan Phase III Trials for Obesity Drug

December 22, 2008 | 
1 min read

TOKYO, Dec 22 (Reuters) - Takeda Pharmaceutical Co Ltd said on Monday it has started late stage or Phase III clinical trials for its ATL-962 obesity drug in Japan.

Clinical research Phase III Asia
Takeda
MORE ON THIS TOPIC
Roche's tower in Shanghai, China
Manufacturing
Roche makes $300M China Production Promise After Multibillion US Investment
May 12, 2025
 · 
2 min read
 · 
Tristan Manalac
istock/ArtemisDiana
PARTNERED
Where AI Adds Real Value in Clinical Development
May 12, 2025
 · 
7 min read
 · 
BioSpace Insights
Drug Development
Eroding Immunity: Vaccine Hesitancy and Cynicism With Paul Offit
May 8, 2025
 · 
1 min read
 · 
Lori Ellis
Computational Biology - The Study of Biological Systems Through Computational Techniques and Modeling - Conceptual Illustration
Gene therapy
CRISPR’s Casgevy on the Rise With More Gene Therapy Proof of Concept To Come in 2025
May 7, 2025
 · 
4 min read
 · 
Annalee Armstrong